First there was BOTOX® Cosmetic (onabotulinumtoxinA), then there was Dysport®, and now a third form of botulinum has entered the cosmetic market called Xeomin®. Officially approved by the FDA in July 2011, Xeomin® offers patients interested in wrinkle removal a new option.

The Food and Drug Administration (FDA) recently approved this new botulinum toxin type A product to treat severe frown lines or "11's" between the eyebrows. Xeomin® was already FDA approved for use in adults with cervical dystonia and blepharospasm.

Xeomin® is used in the same areas of the face and body as BOTOX®.  Here is a brief list of each of these regions treated with Xeomin®.

• Horizontal forehead lines – When we raise our eyebrows, these wrinkles can form in the forehead.
• Vertical frown lines (a.k.a. the 11’s) – When we furrow our brows (such as when we are angery), these vertical or diagonal wrinkles can form.
• Crow’s feet – If someone produces a strong smile with squinting of the eyes, these wrinkles may appear alongside the eyes.
• Brow lift – Using Xeomin® to the outer brows can result in a small (2-3 millimeter brow lift.)
• “smoker’s lines” – Small wrinkles around the mouth when pursing the lips.
• Neck bands – If neck bands form when speaking or smiling, these can respond to Xeomin® treatment.
• Hyperhidrosis / excessive sweating – Xeomin® treats problematic sweating in the scalp, underarms, lower breasts, the palms and the feet.